Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2003
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002079241A3 Secreted streptococcus pneumoniae proteins
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002050117A3 G-proteins coupled receptor proteins and nucleic acids encoding same
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002026933A9 Isoprenoid production
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002020733A3 Genes involved in isoprenoid compound production
08/14/2003WO2002018609A9 Methods for stable transduction of cells with viral vectors
08/14/2003WO2002016584A3 Process for the preparation of neutrophil inhibitory factor
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030154510 Novel delta-endotoxin gene isolated from Bacillus thuringiensis var. finitimus
08/14/2003US20030153740 Cloning libraries with probe which comprises hepatitis B virus (HBV); hap proteins
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153527 Infecting animal cells with live invasive bacteria containing a eukaryotic expression cassette encoding gene, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense RNA or a catalytic RNA
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153079 Agglomerating a nutritive medium powder, medium supplement powder, nutritive medium subgroup powder, or buffer powder with a solvent containing atleast one lipid dissolved for incorporatin in the medium powder
08/14/2003US20030153074 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153058 A gene coding for glutamate dehydrogenase is introduced into a microorganism having L-arginine producing ability to enhance intracellular glutamate dehydrogenase activity and thereby improve the L-arginine producing ability
08/14/2003US20030153057 Method for l-threonine production
08/14/2003US20030153053 Methods for altering polyketide synthase genes
08/14/2003US20030153049 Genetic engineered plasmid vectors; antibiotic resistance; anticancer agents
08/14/2003US20030153048 Novel proteins and methods for producing the proteins
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153045 Methods and compositions for protein expression and purification
08/14/2003US20030153040 Central nervous system disorders; antiinflammatory agents; antidiabetic agents; anticancer agents; hybrid polynucleotide
08/14/2003US20030153028 Cell isolation method
08/14/2003US20030153020 Classification of signal of peptidoglycan; drug screening
08/14/2003US20030153003 Growth hormone variants
08/14/2003US20030152998 Method of preparing cell lysate
08/14/2003US20030152989 Genetic engineering; therapy for liver disease; antitumor agents
08/14/2003US20030152988 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescent dyes
08/14/2003US20030152986 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
08/14/2003US20030152975 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/14/2003US20030152949 Phosphatases
08/14/2003US20030152948 Methods for the simultaneous detection of HCV antigens and HCV antibodies
08/14/2003US20030152935 Comprises hybridization probes; electrophoresis; drug screening
08/14/2003US20030152594 Immunology response intensifiers; administering a bacterial lysate
08/14/2003US20030152589 Infecting with bacteriophage; inducting immunology response; forming antibodies
08/14/2003US20030152587 Immunomoderators; high molecular weight polysaccharides
08/14/2003US20030152586 Dietary supplements comprising growth media
08/14/2003US20030152579 Controlling biosynthesis of hybrid protein; therapy against Helicobacter infections
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475271A1 Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin
08/14/2003CA2475251A1 Proteolytic fermenter
08/14/2003CA2475098A1 Method and test strips for the measurement of fat loss during weight loss programs
08/14/2003CA2475095A1 Degradation of hydrophobic ester pesticides and toxins
08/14/2003CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003CA2474145A1 Bacteriophage lysin
08/14/2003CA2473820A1 Method of production of astaxanthin by fermentation of selected strains of xanthophyllomyces dendrorhous
08/14/2003CA2472765A1 Modulation of sulfate permease for photosynthetic hydrogen production
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003CA2459718A1 Thermus scotoductus nucleic acid polymerases
08/13/2003EP1335024A1 Antibody inhibiting vplf activity
08/13/2003EP1335020A1 Polypeptides having alpha-isomaltosyl transferase activity
08/13/2003EP1334980A1 Multimerized highly functional antifreeze protein
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334206A2 Method and medium for detecting/identifying micro-organisms with esterase and/or osidase and/or peptidase and/or sulphatase and/or phosphatase activity
08/13/2003EP1334205A1 Method for identifying listeria monocytogenes and culture medium
08/13/2003EP1334204A1 Method and medium for detecting/identifying micro-organisms with esterase activity
08/13/2003EP1334203A2 Bacterial extracellular polysaccharide, gluconacetobacter spp. strain producing it and their use in food or pet food products
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334200A2 Multiple inducible gene regulation system
08/13/2003EP1334197A1 Yeast derived vaccine against ipnv
08/13/2003EP1334196A2 Genomic fragment of streptococcus suis and clinical uses thereof
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/13/2003EP1334185A2 Method for producing proteins by electroporation
08/13/2003EP1334183A2 NOVEL SOLUBLE ENDOPROTEASES FOR THE i IN VITRO /i PROCESSING OF RECOMBINANT PROTEINS
08/13/2003EP1334181A2 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
08/13/2003EP1334180A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334178A1 Slo2 and slo4, novel potassium channel proteins from human brain
08/13/2003EP1334176A1 Microorganisms producing l-glutamine and processes for producing l-glutamine using the same
08/13/2003EP1334175A1 Improvements in or relating to selective agents for biological cultures
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/13/2003EP1334122A2 Nucleic acids encoding stichodactylidae chromoproteins
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1333857A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
08/13/2003EP1112495B1 Disaccharide derivatives
08/13/2003EP0989859B1 Cns neuroregenerative compositions and methods of use
08/13/2003EP0859629B1 Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells
1 ... 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 ... 1489